Global GLP-1 Drug Market Growth 2023-2029
The report requires updating with new data and is sent in 101 hours after order is placed.
According to our LPI (LP Information) latest study, the global GLP-1 Drug market size was valued at US$ 19990 million in 2022. With growing demand in downstream market and recovery from influence of COVID-19 and the Russia-Ukraine War, the GLP-1 Drug is forecast to a readjusted size of US$ 104530 million by 2029 with a CAGR of 26.7% during review period.
The research report highlights the growth potential of the global GLP-1 Drug market. With recovery from influence of COVID-19 and the Russia-Ukraine War, GLP-1 Drug are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of GLP-1 Drug. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the GLP-1 Drug market.
Key Features:
The report on GLP-1 Drug market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the GLP-1 Drug market. It may include historical data, market segmentation by Type (e.g., Short-acting GLP-1 Drug, Long-acting GLP-1 Drug), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the GLP-1 Drug market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the GLP-1 Drug market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the GLP-1 Drug industry. This include advancements in GLP-1 Drug technology, GLP-1 Drug new entrants, GLP-1 Drug new investment, and other innovations that are shaping the future of GLP-1 Drug.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the GLP-1 Drug market. It includes factors influencing customer ' purchasing decisions, preferences for GLP-1 Drug product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the GLP-1 Drug market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting GLP-1 Drug market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the GLP-1 Drug market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the GLP-1 Drug industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the GLP-1 Drug market.
Market Segmentation:
GLP-1 Drug market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
What is the 10-year outlook for the global GLP-1 Drug market?
What factors are driving GLP-1 Drug market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do GLP-1 Drug market opportunities vary by end market size?
How does GLP-1 Drug break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
According to our LPI (LP Information) latest study, the global GLP-1 Drug market size was valued at US$ 19990 million in 2022. With growing demand in downstream market and recovery from influence of COVID-19 and the Russia-Ukraine War, the GLP-1 Drug is forecast to a readjusted size of US$ 104530 million by 2029 with a CAGR of 26.7% during review period.
The research report highlights the growth potential of the global GLP-1 Drug market. With recovery from influence of COVID-19 and the Russia-Ukraine War, GLP-1 Drug are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of GLP-1 Drug. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the GLP-1 Drug market.
Key Features:
The report on GLP-1 Drug market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the GLP-1 Drug market. It may include historical data, market segmentation by Type (e.g., Short-acting GLP-1 Drug, Long-acting GLP-1 Drug), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the GLP-1 Drug market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the GLP-1 Drug market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the GLP-1 Drug industry. This include advancements in GLP-1 Drug technology, GLP-1 Drug new entrants, GLP-1 Drug new investment, and other innovations that are shaping the future of GLP-1 Drug.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the GLP-1 Drug market. It includes factors influencing customer ' purchasing decisions, preferences for GLP-1 Drug product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the GLP-1 Drug market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting GLP-1 Drug market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the GLP-1 Drug market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the GLP-1 Drug industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the GLP-1 Drug market.
Market Segmentation:
GLP-1 Drug market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
- Short-acting GLP-1 Drug
- Long-acting GLP-1 Drug
- Obesity
- Type 2 Diabetes (T2DM)
- Cardiovascular and Cerebrovascular Diseases (CVD)
- Non-alcoholic Steatohepatitis (NASH)
- Alzheimer's Disease (AD)
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Eli Lilly
- AstraZeneca
- Sanofi
- Pfizer Inc
- Novo Nordisk
- Boehringer Ingelheim
- GlaxoSmithKline (GSK)
- East China Pharmaceutical Co., Ltd.
- Gan & Lee Pharmaceuticals
- Tonghua Dongbao
- Shanghai Renhui Biopharmaceutical Co., Ltd.
- Jiangsu Hansoh Pharmaceutical Group Co., Ltd.
What is the 10-year outlook for the global GLP-1 Drug market?
What factors are driving GLP-1 Drug market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do GLP-1 Drug market opportunities vary by end market size?
How does GLP-1 Drug break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global GLP-1 Drug Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for GLP-1 Drug by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for GLP-1 Drug by Country/Region, 2018, 2022 & 2029
2.2 GLP-1 Drug Segment by Type
2.2.1 Short-acting GLP-1 Drug
2.2.2 Long-acting GLP-1 Drug
2.3 GLP-1 Drug Sales by Type
2.3.1 Global GLP-1 Drug Sales Market Share by Type (2018-2023)
2.3.2 Global GLP-1 Drug Revenue and Market Share by Type (2018-2023)
2.3.3 Global GLP-1 Drug Sale Price by Type (2018-2023)
2.4 GLP-1 Drug Segment by Application
2.4.1 Obesity
2.4.2 Type 2 Diabetes (T2DM)
2.4.3 Cardiovascular and Cerebrovascular Diseases (CVD)
2.4.4 Non-alcoholic Steatohepatitis (NASH)
2.4.5 Alzheimer's Disease (AD)
2.5 GLP-1 Drug Sales by Application
2.5.1 Global GLP-1 Drug Sale Market Share by Application (2018-2023)
2.5.2 Global GLP-1 Drug Revenue and Market Share by Application (2018-2023)
2.5.3 Global GLP-1 Drug Sale Price by Application (2018-2023)
3 GLOBAL GLP-1 DRUG BY COMPANY
3.1 Global GLP-1 Drug Breakdown Data by Company
3.1.1 Global GLP-1 Drug Annual Sales by Company (2018-2023)
3.1.2 Global GLP-1 Drug Sales Market Share by Company (2018-2023)
3.2 Global GLP-1 Drug Annual Revenue by Company (2018-2023)
3.2.1 Global GLP-1 Drug Revenue by Company (2018-2023)
3.2.2 Global GLP-1 Drug Revenue Market Share by Company (2018-2023)
3.3 Global GLP-1 Drug Sale Price by Company
3.4 Key Manufacturers GLP-1 Drug Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers GLP-1 Drug Product Location Distribution
3.4.2 Players GLP-1 Drug Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR GLP-1 DRUG BY GEOGRAPHIC REGION
4.1 World Historic GLP-1 Drug Market Size by Geographic Region (2018-2023)
4.1.1 Global GLP-1 Drug Annual Sales by Geographic Region (2018-2023)
4.1.2 Global GLP-1 Drug Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic GLP-1 Drug Market Size by Country/Region (2018-2023)
4.2.1 Global GLP-1 Drug Annual Sales by Country/Region (2018-2023)
4.2.2 Global GLP-1 Drug Annual Revenue by Country/Region (2018-2023)
4.3 Americas GLP-1 Drug Sales Growth
4.4 APAC GLP-1 Drug Sales Growth
4.5 Europe GLP-1 Drug Sales Growth
4.6 Middle East & Africa GLP-1 Drug Sales Growth
5 AMERICAS
5.1 Americas GLP-1 Drug Sales by Country
5.1.1 Americas GLP-1 Drug Sales by Country (2018-2023)
5.1.2 Americas GLP-1 Drug Revenue by Country (2018-2023)
5.2 Americas GLP-1 Drug Sales by Type
5.3 Americas GLP-1 Drug Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC GLP-1 Drug Sales by Region
6.1.1 APAC GLP-1 Drug Sales by Region (2018-2023)
6.1.2 APAC GLP-1 Drug Revenue by Region (2018-2023)
6.2 APAC GLP-1 Drug Sales by Type
6.3 APAC GLP-1 Drug Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe GLP-1 Drug by Country
7.1.1 Europe GLP-1 Drug Sales by Country (2018-2023)
7.1.2 Europe GLP-1 Drug Revenue by Country (2018-2023)
7.2 Europe GLP-1 Drug Sales by Type
7.3 Europe GLP-1 Drug Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa GLP-1 Drug by Country
8.1.1 Middle East & Africa GLP-1 Drug Sales by Country (2018-2023)
8.1.2 Middle East & Africa GLP-1 Drug Revenue by Country (2018-2023)
8.2 Middle East & Africa GLP-1 Drug Sales by Type
8.3 Middle East & Africa GLP-1 Drug Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of GLP-1 Drug
10.3 Manufacturing Process Analysis of GLP-1 Drug
10.4 Industry Chain Structure of GLP-1 Drug
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 GLP-1 Drug Distributors
11.3 GLP-1 Drug Customer
12 WORLD FORECAST REVIEW FOR GLP-1 DRUG BY GEOGRAPHIC REGION
12.1 Global GLP-1 Drug Market Size Forecast by Region
12.1.1 Global GLP-1 Drug Forecast by Region (2024-2029)
12.1.2 Global GLP-1 Drug Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global GLP-1 Drug Forecast by Type
12.7 Global GLP-1 Drug Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Eli Lilly
13.1.1 Eli Lilly Company Information
13.1.2 Eli Lilly GLP-1 Drug Product Portfolios and Specifications
13.1.3 Eli Lilly GLP-1 Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Eli Lilly Main Business Overview
13.1.5 Eli Lilly Latest Developments
13.2 AstraZeneca
13.2.1 AstraZeneca Company Information
13.2.2 AstraZeneca GLP-1 Drug Product Portfolios and Specifications
13.2.3 AstraZeneca GLP-1 Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 AstraZeneca Main Business Overview
13.2.5 AstraZeneca Latest Developments
13.3 Sanofi
13.3.1 Sanofi Company Information
13.3.2 Sanofi GLP-1 Drug Product Portfolios and Specifications
13.3.3 Sanofi GLP-1 Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Sanofi Main Business Overview
13.3.5 Sanofi Latest Developments
13.4 Pfizer Inc
13.4.1 Pfizer Inc Company Information
13.4.2 Pfizer Inc GLP-1 Drug Product Portfolios and Specifications
13.4.3 Pfizer Inc GLP-1 Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Pfizer Inc Main Business Overview
13.4.5 Pfizer Inc Latest Developments
13.5 Novo Nordisk
13.5.1 Novo Nordisk Company Information
13.5.2 Novo Nordisk GLP-1 Drug Product Portfolios and Specifications
13.5.3 Novo Nordisk GLP-1 Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Novo Nordisk Main Business Overview
13.5.5 Novo Nordisk Latest Developments
13.6 Boehringer Ingelheim
13.6.1 Boehringer Ingelheim Company Information
13.6.2 Boehringer Ingelheim GLP-1 Drug Product Portfolios and Specifications
13.6.3 Boehringer Ingelheim GLP-1 Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Boehringer Ingelheim Main Business Overview
13.6.5 Boehringer Ingelheim Latest Developments
13.7 GlaxoSmithKline (GSK)
13.7.1 GlaxoSmithKline (GSK) Company Information
13.7.2 GlaxoSmithKline (GSK) GLP-1 Drug Product Portfolios and Specifications
13.7.3 GlaxoSmithKline (GSK) GLP-1 Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 GlaxoSmithKline (GSK) Main Business Overview
13.7.5 GlaxoSmithKline (GSK) Latest Developments
13.8 East China Pharmaceutical Co., Ltd.
13.8.1 East China Pharmaceutical Co., Ltd. Company Information
13.8.2 East China Pharmaceutical Co., Ltd. GLP-1 Drug Product Portfolios and Specifications
13.8.3 East China Pharmaceutical Co., Ltd. GLP-1 Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 East China Pharmaceutical Co., Ltd. Main Business Overview
13.8.5 East China Pharmaceutical Co., Ltd. Latest Developments
13.9 Gan & Lee Pharmaceuticals
13.9.1 Gan & Lee Pharmaceuticals Company Information
13.9.2 Gan & Lee Pharmaceuticals GLP-1 Drug Product Portfolios and Specifications
13.9.3 Gan & Lee Pharmaceuticals GLP-1 Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Gan & Lee Pharmaceuticals Main Business Overview
13.9.5 Gan & Lee Pharmaceuticals Latest Developments
13.10 Tonghua Dongbao
13.10.1 Tonghua Dongbao Company Information
13.10.2 Tonghua Dongbao GLP-1 Drug Product Portfolios and Specifications
13.10.3 Tonghua Dongbao GLP-1 Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Tonghua Dongbao Main Business Overview
13.10.5 Tonghua Dongbao Latest Developments
13.11 Shanghai Renhui Biopharmaceutical Co., Ltd.
13.11.1 Shanghai Renhui Biopharmaceutical Co., Ltd. Company Information
13.11.2 Shanghai Renhui Biopharmaceutical Co., Ltd. GLP-1 Drug Product Portfolios and Specifications
13.11.3 Shanghai Renhui Biopharmaceutical Co., Ltd. GLP-1 Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Shanghai Renhui Biopharmaceutical Co., Ltd. Main Business Overview
13.11.5 Shanghai Renhui Biopharmaceutical Co., Ltd. Latest Developments
13.12 Jiangsu Hansoh Pharmaceutical Group Co., Ltd.
13.12.1 Jiangsu Hansoh Pharmaceutical Group Co., Ltd. Company Information
13.12.2 Jiangsu Hansoh Pharmaceutical Group Co., Ltd. GLP-1 Drug Product Portfolios and Specifications
13.12.3 Jiangsu Hansoh Pharmaceutical Group Co., Ltd. GLP-1 Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Jiangsu Hansoh Pharmaceutical Group Co., Ltd. Main Business Overview
13.12.5 Jiangsu Hansoh Pharmaceutical Group Co., Ltd. Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global GLP-1 Drug Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for GLP-1 Drug by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for GLP-1 Drug by Country/Region, 2018, 2022 & 2029
2.2 GLP-1 Drug Segment by Type
2.2.1 Short-acting GLP-1 Drug
2.2.2 Long-acting GLP-1 Drug
2.3 GLP-1 Drug Sales by Type
2.3.1 Global GLP-1 Drug Sales Market Share by Type (2018-2023)
2.3.2 Global GLP-1 Drug Revenue and Market Share by Type (2018-2023)
2.3.3 Global GLP-1 Drug Sale Price by Type (2018-2023)
2.4 GLP-1 Drug Segment by Application
2.4.1 Obesity
2.4.2 Type 2 Diabetes (T2DM)
2.4.3 Cardiovascular and Cerebrovascular Diseases (CVD)
2.4.4 Non-alcoholic Steatohepatitis (NASH)
2.4.5 Alzheimer's Disease (AD)
2.5 GLP-1 Drug Sales by Application
2.5.1 Global GLP-1 Drug Sale Market Share by Application (2018-2023)
2.5.2 Global GLP-1 Drug Revenue and Market Share by Application (2018-2023)
2.5.3 Global GLP-1 Drug Sale Price by Application (2018-2023)
3 GLOBAL GLP-1 DRUG BY COMPANY
3.1 Global GLP-1 Drug Breakdown Data by Company
3.1.1 Global GLP-1 Drug Annual Sales by Company (2018-2023)
3.1.2 Global GLP-1 Drug Sales Market Share by Company (2018-2023)
3.2 Global GLP-1 Drug Annual Revenue by Company (2018-2023)
3.2.1 Global GLP-1 Drug Revenue by Company (2018-2023)
3.2.2 Global GLP-1 Drug Revenue Market Share by Company (2018-2023)
3.3 Global GLP-1 Drug Sale Price by Company
3.4 Key Manufacturers GLP-1 Drug Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers GLP-1 Drug Product Location Distribution
3.4.2 Players GLP-1 Drug Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR GLP-1 DRUG BY GEOGRAPHIC REGION
4.1 World Historic GLP-1 Drug Market Size by Geographic Region (2018-2023)
4.1.1 Global GLP-1 Drug Annual Sales by Geographic Region (2018-2023)
4.1.2 Global GLP-1 Drug Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic GLP-1 Drug Market Size by Country/Region (2018-2023)
4.2.1 Global GLP-1 Drug Annual Sales by Country/Region (2018-2023)
4.2.2 Global GLP-1 Drug Annual Revenue by Country/Region (2018-2023)
4.3 Americas GLP-1 Drug Sales Growth
4.4 APAC GLP-1 Drug Sales Growth
4.5 Europe GLP-1 Drug Sales Growth
4.6 Middle East & Africa GLP-1 Drug Sales Growth
5 AMERICAS
5.1 Americas GLP-1 Drug Sales by Country
5.1.1 Americas GLP-1 Drug Sales by Country (2018-2023)
5.1.2 Americas GLP-1 Drug Revenue by Country (2018-2023)
5.2 Americas GLP-1 Drug Sales by Type
5.3 Americas GLP-1 Drug Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC GLP-1 Drug Sales by Region
6.1.1 APAC GLP-1 Drug Sales by Region (2018-2023)
6.1.2 APAC GLP-1 Drug Revenue by Region (2018-2023)
6.2 APAC GLP-1 Drug Sales by Type
6.3 APAC GLP-1 Drug Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe GLP-1 Drug by Country
7.1.1 Europe GLP-1 Drug Sales by Country (2018-2023)
7.1.2 Europe GLP-1 Drug Revenue by Country (2018-2023)
7.2 Europe GLP-1 Drug Sales by Type
7.3 Europe GLP-1 Drug Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa GLP-1 Drug by Country
8.1.1 Middle East & Africa GLP-1 Drug Sales by Country (2018-2023)
8.1.2 Middle East & Africa GLP-1 Drug Revenue by Country (2018-2023)
8.2 Middle East & Africa GLP-1 Drug Sales by Type
8.3 Middle East & Africa GLP-1 Drug Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of GLP-1 Drug
10.3 Manufacturing Process Analysis of GLP-1 Drug
10.4 Industry Chain Structure of GLP-1 Drug
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 GLP-1 Drug Distributors
11.3 GLP-1 Drug Customer
12 WORLD FORECAST REVIEW FOR GLP-1 DRUG BY GEOGRAPHIC REGION
12.1 Global GLP-1 Drug Market Size Forecast by Region
12.1.1 Global GLP-1 Drug Forecast by Region (2024-2029)
12.1.2 Global GLP-1 Drug Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global GLP-1 Drug Forecast by Type
12.7 Global GLP-1 Drug Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Eli Lilly
13.1.1 Eli Lilly Company Information
13.1.2 Eli Lilly GLP-1 Drug Product Portfolios and Specifications
13.1.3 Eli Lilly GLP-1 Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Eli Lilly Main Business Overview
13.1.5 Eli Lilly Latest Developments
13.2 AstraZeneca
13.2.1 AstraZeneca Company Information
13.2.2 AstraZeneca GLP-1 Drug Product Portfolios and Specifications
13.2.3 AstraZeneca GLP-1 Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 AstraZeneca Main Business Overview
13.2.5 AstraZeneca Latest Developments
13.3 Sanofi
13.3.1 Sanofi Company Information
13.3.2 Sanofi GLP-1 Drug Product Portfolios and Specifications
13.3.3 Sanofi GLP-1 Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Sanofi Main Business Overview
13.3.5 Sanofi Latest Developments
13.4 Pfizer Inc
13.4.1 Pfizer Inc Company Information
13.4.2 Pfizer Inc GLP-1 Drug Product Portfolios and Specifications
13.4.3 Pfizer Inc GLP-1 Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Pfizer Inc Main Business Overview
13.4.5 Pfizer Inc Latest Developments
13.5 Novo Nordisk
13.5.1 Novo Nordisk Company Information
13.5.2 Novo Nordisk GLP-1 Drug Product Portfolios and Specifications
13.5.3 Novo Nordisk GLP-1 Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Novo Nordisk Main Business Overview
13.5.5 Novo Nordisk Latest Developments
13.6 Boehringer Ingelheim
13.6.1 Boehringer Ingelheim Company Information
13.6.2 Boehringer Ingelheim GLP-1 Drug Product Portfolios and Specifications
13.6.3 Boehringer Ingelheim GLP-1 Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Boehringer Ingelheim Main Business Overview
13.6.5 Boehringer Ingelheim Latest Developments
13.7 GlaxoSmithKline (GSK)
13.7.1 GlaxoSmithKline (GSK) Company Information
13.7.2 GlaxoSmithKline (GSK) GLP-1 Drug Product Portfolios and Specifications
13.7.3 GlaxoSmithKline (GSK) GLP-1 Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 GlaxoSmithKline (GSK) Main Business Overview
13.7.5 GlaxoSmithKline (GSK) Latest Developments
13.8 East China Pharmaceutical Co., Ltd.
13.8.1 East China Pharmaceutical Co., Ltd. Company Information
13.8.2 East China Pharmaceutical Co., Ltd. GLP-1 Drug Product Portfolios and Specifications
13.8.3 East China Pharmaceutical Co., Ltd. GLP-1 Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 East China Pharmaceutical Co., Ltd. Main Business Overview
13.8.5 East China Pharmaceutical Co., Ltd. Latest Developments
13.9 Gan & Lee Pharmaceuticals
13.9.1 Gan & Lee Pharmaceuticals Company Information
13.9.2 Gan & Lee Pharmaceuticals GLP-1 Drug Product Portfolios and Specifications
13.9.3 Gan & Lee Pharmaceuticals GLP-1 Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Gan & Lee Pharmaceuticals Main Business Overview
13.9.5 Gan & Lee Pharmaceuticals Latest Developments
13.10 Tonghua Dongbao
13.10.1 Tonghua Dongbao Company Information
13.10.2 Tonghua Dongbao GLP-1 Drug Product Portfolios and Specifications
13.10.3 Tonghua Dongbao GLP-1 Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Tonghua Dongbao Main Business Overview
13.10.5 Tonghua Dongbao Latest Developments
13.11 Shanghai Renhui Biopharmaceutical Co., Ltd.
13.11.1 Shanghai Renhui Biopharmaceutical Co., Ltd. Company Information
13.11.2 Shanghai Renhui Biopharmaceutical Co., Ltd. GLP-1 Drug Product Portfolios and Specifications
13.11.3 Shanghai Renhui Biopharmaceutical Co., Ltd. GLP-1 Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Shanghai Renhui Biopharmaceutical Co., Ltd. Main Business Overview
13.11.5 Shanghai Renhui Biopharmaceutical Co., Ltd. Latest Developments
13.12 Jiangsu Hansoh Pharmaceutical Group Co., Ltd.
13.12.1 Jiangsu Hansoh Pharmaceutical Group Co., Ltd. Company Information
13.12.2 Jiangsu Hansoh Pharmaceutical Group Co., Ltd. GLP-1 Drug Product Portfolios and Specifications
13.12.3 Jiangsu Hansoh Pharmaceutical Group Co., Ltd. GLP-1 Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Jiangsu Hansoh Pharmaceutical Group Co., Ltd. Main Business Overview
13.12.5 Jiangsu Hansoh Pharmaceutical Group Co., Ltd. Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. GLP-1 Drug Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. GLP-1 Drug Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Short-acting GLP-1 Drug
Table 4. Major Players of Long-acting GLP-1 Drug
Table 5. Global GLP-1 Drug Sales by Type (2018-2023) & (K Units)
Table 6. Global GLP-1 Drug Sales Market Share by Type (2018-2023)
Table 7. Global GLP-1 Drug Revenue by Type (2018-2023) & ($ million)
Table 8. Global GLP-1 Drug Revenue Market Share by Type (2018-2023)
Table 9. Global GLP-1 Drug Sale Price by Type (2018-2023) & (US$/Unit)
Table 10. Global GLP-1 Drug Sales by Application (2018-2023) & (K Units)
Table 11. Global GLP-1 Drug Sales Market Share by Application (2018-2023)
Table 12. Global GLP-1 Drug Revenue by Application (2018-2023)
Table 13. Global GLP-1 Drug Revenue Market Share by Application (2018-2023)
Table 14. Global GLP-1 Drug Sale Price by Application (2018-2023) & (US$/Unit)
Table 15. Global GLP-1 Drug Sales by Company (2018-2023) & (K Units)
Table 16. Global GLP-1 Drug Sales Market Share by Company (2018-2023)
Table 17. Global GLP-1 Drug Revenue by Company (2018-2023) ($ Millions)
Table 18. Global GLP-1 Drug Revenue Market Share by Company (2018-2023)
Table 19. Global GLP-1 Drug Sale Price by Company (2018-2023) & (US$/Unit)
Table 20. Key Manufacturers GLP-1 Drug Producing Area Distribution and Sales Area
Table 21. Players GLP-1 Drug Products Offered
Table 22. GLP-1 Drug Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global GLP-1 Drug Sales by Geographic Region (2018-2023) & (K Units)
Table 26. Global GLP-1 Drug Sales Market Share Geographic Region (2018-2023)
Table 27. Global GLP-1 Drug Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global GLP-1 Drug Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global GLP-1 Drug Sales by Country/Region (2018-2023) & (K Units)
Table 30. Global GLP-1 Drug Sales Market Share by Country/Region (2018-2023)
Table 31. Global GLP-1 Drug Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global GLP-1 Drug Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas GLP-1 Drug Sales by Country (2018-2023) & (K Units)
Table 34. Americas GLP-1 Drug Sales Market Share by Country (2018-2023)
Table 35. Americas GLP-1 Drug Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas GLP-1 Drug Revenue Market Share by Country (2018-2023)
Table 37. Americas GLP-1 Drug Sales by Type (2018-2023) & (K Units)
Table 38. Americas GLP-1 Drug Sales by Application (2018-2023) & (K Units)
Table 39. APAC GLP-1 Drug Sales by Region (2018-2023) & (K Units)
Table 40. APAC GLP-1 Drug Sales Market Share by Region (2018-2023)
Table 41. APAC GLP-1 Drug Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC GLP-1 Drug Revenue Market Share by Region (2018-2023)
Table 43. APAC GLP-1 Drug Sales by Type (2018-2023) & (K Units)
Table 44. APAC GLP-1 Drug Sales by Application (2018-2023) & (K Units)
Table 45. Europe GLP-1 Drug Sales by Country (2018-2023) & (K Units)
Table 46. Europe GLP-1 Drug Sales Market Share by Country (2018-2023)
Table 47. Europe GLP-1 Drug Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe GLP-1 Drug Revenue Market Share by Country (2018-2023)
Table 49. Europe GLP-1 Drug Sales by Type (2018-2023) & (K Units)
Table 50. Europe GLP-1 Drug Sales by Application (2018-2023) & (K Units)
Table 51. Middle East & Africa GLP-1 Drug Sales by Country (2018-2023) & (K Units)
Table 52. Middle East & Africa GLP-1 Drug Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa GLP-1 Drug Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa GLP-1 Drug Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa GLP-1 Drug Sales by Type (2018-2023) & (K Units)
Table 56. Middle East & Africa GLP-1 Drug Sales by Application (2018-2023) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of GLP-1 Drug
Table 58. Key Market Challenges & Risks of GLP-1 Drug
Table 59. Key Industry Trends of GLP-1 Drug
Table 60. GLP-1 Drug Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. GLP-1 Drug Distributors List
Table 63. GLP-1 Drug Customer List
Table 64. Global GLP-1 Drug Sales Forecast by Region (2024-2029) & (K Units)
Table 65. Global GLP-1 Drug Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas GLP-1 Drug Sales Forecast by Country (2024-2029) & (K Units)
Table 67. Americas GLP-1 Drug Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC GLP-1 Drug Sales Forecast by Region (2024-2029) & (K Units)
Table 69. APAC GLP-1 Drug Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe GLP-1 Drug Sales Forecast by Country (2024-2029) & (K Units)
Table 71. Europe GLP-1 Drug Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa GLP-1 Drug Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Middle East & Africa GLP-1 Drug Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global GLP-1 Drug Sales Forecast by Type (2024-2029) & (K Units)
Table 75. Global GLP-1 Drug Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global GLP-1 Drug Sales Forecast by Application (2024-2029) & (K Units)
Table 77. Global GLP-1 Drug Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Eli Lilly Basic Information, GLP-1 Drug Manufacturing Base, Sales Area and Its Competitors
Table 79. Eli Lilly GLP-1 Drug Product Portfolios and Specifications
Table 80. Eli Lilly GLP-1 Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 81. Eli Lilly Main Business
Table 82. Eli Lilly Latest Developments
Table 83. AstraZeneca Basic Information, GLP-1 Drug Manufacturing Base, Sales Area and Its Competitors
Table 84. AstraZeneca GLP-1 Drug Product Portfolios and Specifications
Table 85. AstraZeneca GLP-1 Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 86. AstraZeneca Main Business
Table 87. AstraZeneca Latest Developments
Table 88. Sanofi Basic Information, GLP-1 Drug Manufacturing Base, Sales Area and Its Competitors
Table 89. Sanofi GLP-1 Drug Product Portfolios and Specifications
Table 90. Sanofi GLP-1 Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 91. Sanofi Main Business
Table 92. Sanofi Latest Developments
Table 93. Pfizer Inc Basic Information, GLP-1 Drug Manufacturing Base, Sales Area and Its Competitors
Table 94. Pfizer Inc GLP-1 Drug Product Portfolios and Specifications
Table 95. Pfizer Inc GLP-1 Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 96. Pfizer Inc Main Business
Table 97. Pfizer Inc Latest Developments
Table 98. Novo Nordisk Basic Information, GLP-1 Drug Manufacturing Base, Sales Area and Its Competitors
Table 99. Novo Nordisk GLP-1 Drug Product Portfolios and Specifications
Table 100. Novo Nordisk GLP-1 Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 101. Novo Nordisk Main Business
Table 102. Novo Nordisk Latest Developments
Table 103. Boehringer Ingelheim Basic Information, GLP-1 Drug Manufacturing Base, Sales Area and Its Competitors
Table 104. Boehringer Ingelheim GLP-1 Drug Product Portfolios and Specifications
Table 105. Boehringer Ingelheim GLP-1 Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 106. Boehringer Ingelheim Main Business
Table 107. Boehringer Ingelheim Latest Developments
Table 108. GlaxoSmithKline (GSK) Basic Information, GLP-1 Drug Manufacturing Base, Sales Area and Its Competitors
Table 109. GlaxoSmithKline (GSK) GLP-1 Drug Product Portfolios and Specifications
Table 110. GlaxoSmithKline (GSK) GLP-1 Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 111. GlaxoSmithKline (GSK) Main Business
Table 112. GlaxoSmithKline (GSK) Latest Developments
Table 113. East China Pharmaceutical Co., Ltd. Basic Information, GLP-1 Drug Manufacturing Base, Sales Area and Its Competitors
Table 114. East China Pharmaceutical Co., Ltd. GLP-1 Drug Product Portfolios and Specifications
Table 115. East China Pharmaceutical Co., Ltd. GLP-1 Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 116. East China Pharmaceutical Co., Ltd. Main Business
Table 117. East China Pharmaceutical Co., Ltd. Latest Developments
Table 118. Gan & Lee Pharmaceuticals Basic Information, GLP-1 Drug Manufacturing Base, Sales Area and Its Competitors
Table 119. Gan & Lee Pharmaceuticals GLP-1 Drug Product Portfolios and Specifications
Table 120. Gan & Lee Pharmaceuticals GLP-1 Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 121. Gan & Lee Pharmaceuticals Main Business
Table 122. Gan & Lee Pharmaceuticals Latest Developments
Table 123. Tonghua Dongbao Basic Information, GLP-1 Drug Manufacturing Base, Sales Area and Its Competitors
Table 124. Tonghua Dongbao GLP-1 Drug Product Portfolios and Specifications
Table 125. Tonghua Dongbao GLP-1 Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 126. Tonghua Dongbao Main Business
Table 127. Tonghua Dongbao Latest Developments
Table 128. Shanghai Renhui Biopharmaceutical Co., Ltd. Basic Information, GLP-1 Drug Manufacturing Base, Sales Area and Its Competitors
Table 129. Shanghai Renhui Biopharmaceutical Co., Ltd. GLP-1 Drug Product Portfolios and Specifications
Table 130. Shanghai Renhui Biopharmaceutical Co., Ltd. GLP-1 Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 131. Shanghai Renhui Biopharmaceutical Co., Ltd. Main Business
Table 132. Shanghai Renhui Biopharmaceutical Co., Ltd. Latest Developments
Table 133. Jiangsu Hansoh Pharmaceutical Group Co., Ltd. Basic Information, GLP-1 Drug Manufacturing Base, Sales Area and Its Competitors
Table 134. Jiangsu Hansoh Pharmaceutical Group Co., Ltd. GLP-1 Drug Product Portfolios and Specifications
Table 135. Jiangsu Hansoh Pharmaceutical Group Co., Ltd. GLP-1 Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 136. Jiangsu Hansoh Pharmaceutical Group Co., Ltd. Main Business
Table 137. Jiangsu Hansoh Pharmaceutical Group Co., Ltd. Latest Developments
Table 1. GLP-1 Drug Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. GLP-1 Drug Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Short-acting GLP-1 Drug
Table 4. Major Players of Long-acting GLP-1 Drug
Table 5. Global GLP-1 Drug Sales by Type (2018-2023) & (K Units)
Table 6. Global GLP-1 Drug Sales Market Share by Type (2018-2023)
Table 7. Global GLP-1 Drug Revenue by Type (2018-2023) & ($ million)
Table 8. Global GLP-1 Drug Revenue Market Share by Type (2018-2023)
Table 9. Global GLP-1 Drug Sale Price by Type (2018-2023) & (US$/Unit)
Table 10. Global GLP-1 Drug Sales by Application (2018-2023) & (K Units)
Table 11. Global GLP-1 Drug Sales Market Share by Application (2018-2023)
Table 12. Global GLP-1 Drug Revenue by Application (2018-2023)
Table 13. Global GLP-1 Drug Revenue Market Share by Application (2018-2023)
Table 14. Global GLP-1 Drug Sale Price by Application (2018-2023) & (US$/Unit)
Table 15. Global GLP-1 Drug Sales by Company (2018-2023) & (K Units)
Table 16. Global GLP-1 Drug Sales Market Share by Company (2018-2023)
Table 17. Global GLP-1 Drug Revenue by Company (2018-2023) ($ Millions)
Table 18. Global GLP-1 Drug Revenue Market Share by Company (2018-2023)
Table 19. Global GLP-1 Drug Sale Price by Company (2018-2023) & (US$/Unit)
Table 20. Key Manufacturers GLP-1 Drug Producing Area Distribution and Sales Area
Table 21. Players GLP-1 Drug Products Offered
Table 22. GLP-1 Drug Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global GLP-1 Drug Sales by Geographic Region (2018-2023) & (K Units)
Table 26. Global GLP-1 Drug Sales Market Share Geographic Region (2018-2023)
Table 27. Global GLP-1 Drug Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global GLP-1 Drug Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global GLP-1 Drug Sales by Country/Region (2018-2023) & (K Units)
Table 30. Global GLP-1 Drug Sales Market Share by Country/Region (2018-2023)
Table 31. Global GLP-1 Drug Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global GLP-1 Drug Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas GLP-1 Drug Sales by Country (2018-2023) & (K Units)
Table 34. Americas GLP-1 Drug Sales Market Share by Country (2018-2023)
Table 35. Americas GLP-1 Drug Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas GLP-1 Drug Revenue Market Share by Country (2018-2023)
Table 37. Americas GLP-1 Drug Sales by Type (2018-2023) & (K Units)
Table 38. Americas GLP-1 Drug Sales by Application (2018-2023) & (K Units)
Table 39. APAC GLP-1 Drug Sales by Region (2018-2023) & (K Units)
Table 40. APAC GLP-1 Drug Sales Market Share by Region (2018-2023)
Table 41. APAC GLP-1 Drug Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC GLP-1 Drug Revenue Market Share by Region (2018-2023)
Table 43. APAC GLP-1 Drug Sales by Type (2018-2023) & (K Units)
Table 44. APAC GLP-1 Drug Sales by Application (2018-2023) & (K Units)
Table 45. Europe GLP-1 Drug Sales by Country (2018-2023) & (K Units)
Table 46. Europe GLP-1 Drug Sales Market Share by Country (2018-2023)
Table 47. Europe GLP-1 Drug Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe GLP-1 Drug Revenue Market Share by Country (2018-2023)
Table 49. Europe GLP-1 Drug Sales by Type (2018-2023) & (K Units)
Table 50. Europe GLP-1 Drug Sales by Application (2018-2023) & (K Units)
Table 51. Middle East & Africa GLP-1 Drug Sales by Country (2018-2023) & (K Units)
Table 52. Middle East & Africa GLP-1 Drug Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa GLP-1 Drug Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa GLP-1 Drug Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa GLP-1 Drug Sales by Type (2018-2023) & (K Units)
Table 56. Middle East & Africa GLP-1 Drug Sales by Application (2018-2023) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of GLP-1 Drug
Table 58. Key Market Challenges & Risks of GLP-1 Drug
Table 59. Key Industry Trends of GLP-1 Drug
Table 60. GLP-1 Drug Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. GLP-1 Drug Distributors List
Table 63. GLP-1 Drug Customer List
Table 64. Global GLP-1 Drug Sales Forecast by Region (2024-2029) & (K Units)
Table 65. Global GLP-1 Drug Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas GLP-1 Drug Sales Forecast by Country (2024-2029) & (K Units)
Table 67. Americas GLP-1 Drug Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC GLP-1 Drug Sales Forecast by Region (2024-2029) & (K Units)
Table 69. APAC GLP-1 Drug Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe GLP-1 Drug Sales Forecast by Country (2024-2029) & (K Units)
Table 71. Europe GLP-1 Drug Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa GLP-1 Drug Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Middle East & Africa GLP-1 Drug Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global GLP-1 Drug Sales Forecast by Type (2024-2029) & (K Units)
Table 75. Global GLP-1 Drug Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global GLP-1 Drug Sales Forecast by Application (2024-2029) & (K Units)
Table 77. Global GLP-1 Drug Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Eli Lilly Basic Information, GLP-1 Drug Manufacturing Base, Sales Area and Its Competitors
Table 79. Eli Lilly GLP-1 Drug Product Portfolios and Specifications
Table 80. Eli Lilly GLP-1 Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 81. Eli Lilly Main Business
Table 82. Eli Lilly Latest Developments
Table 83. AstraZeneca Basic Information, GLP-1 Drug Manufacturing Base, Sales Area and Its Competitors
Table 84. AstraZeneca GLP-1 Drug Product Portfolios and Specifications
Table 85. AstraZeneca GLP-1 Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 86. AstraZeneca Main Business
Table 87. AstraZeneca Latest Developments
Table 88. Sanofi Basic Information, GLP-1 Drug Manufacturing Base, Sales Area and Its Competitors
Table 89. Sanofi GLP-1 Drug Product Portfolios and Specifications
Table 90. Sanofi GLP-1 Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 91. Sanofi Main Business
Table 92. Sanofi Latest Developments
Table 93. Pfizer Inc Basic Information, GLP-1 Drug Manufacturing Base, Sales Area and Its Competitors
Table 94. Pfizer Inc GLP-1 Drug Product Portfolios and Specifications
Table 95. Pfizer Inc GLP-1 Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 96. Pfizer Inc Main Business
Table 97. Pfizer Inc Latest Developments
Table 98. Novo Nordisk Basic Information, GLP-1 Drug Manufacturing Base, Sales Area and Its Competitors
Table 99. Novo Nordisk GLP-1 Drug Product Portfolios and Specifications
Table 100. Novo Nordisk GLP-1 Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 101. Novo Nordisk Main Business
Table 102. Novo Nordisk Latest Developments
Table 103. Boehringer Ingelheim Basic Information, GLP-1 Drug Manufacturing Base, Sales Area and Its Competitors
Table 104. Boehringer Ingelheim GLP-1 Drug Product Portfolios and Specifications
Table 105. Boehringer Ingelheim GLP-1 Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 106. Boehringer Ingelheim Main Business
Table 107. Boehringer Ingelheim Latest Developments
Table 108. GlaxoSmithKline (GSK) Basic Information, GLP-1 Drug Manufacturing Base, Sales Area and Its Competitors
Table 109. GlaxoSmithKline (GSK) GLP-1 Drug Product Portfolios and Specifications
Table 110. GlaxoSmithKline (GSK) GLP-1 Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 111. GlaxoSmithKline (GSK) Main Business
Table 112. GlaxoSmithKline (GSK) Latest Developments
Table 113. East China Pharmaceutical Co., Ltd. Basic Information, GLP-1 Drug Manufacturing Base, Sales Area and Its Competitors
Table 114. East China Pharmaceutical Co., Ltd. GLP-1 Drug Product Portfolios and Specifications
Table 115. East China Pharmaceutical Co., Ltd. GLP-1 Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 116. East China Pharmaceutical Co., Ltd. Main Business
Table 117. East China Pharmaceutical Co., Ltd. Latest Developments
Table 118. Gan & Lee Pharmaceuticals Basic Information, GLP-1 Drug Manufacturing Base, Sales Area and Its Competitors
Table 119. Gan & Lee Pharmaceuticals GLP-1 Drug Product Portfolios and Specifications
Table 120. Gan & Lee Pharmaceuticals GLP-1 Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 121. Gan & Lee Pharmaceuticals Main Business
Table 122. Gan & Lee Pharmaceuticals Latest Developments
Table 123. Tonghua Dongbao Basic Information, GLP-1 Drug Manufacturing Base, Sales Area and Its Competitors
Table 124. Tonghua Dongbao GLP-1 Drug Product Portfolios and Specifications
Table 125. Tonghua Dongbao GLP-1 Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 126. Tonghua Dongbao Main Business
Table 127. Tonghua Dongbao Latest Developments
Table 128. Shanghai Renhui Biopharmaceutical Co., Ltd. Basic Information, GLP-1 Drug Manufacturing Base, Sales Area and Its Competitors
Table 129. Shanghai Renhui Biopharmaceutical Co., Ltd. GLP-1 Drug Product Portfolios and Specifications
Table 130. Shanghai Renhui Biopharmaceutical Co., Ltd. GLP-1 Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 131. Shanghai Renhui Biopharmaceutical Co., Ltd. Main Business
Table 132. Shanghai Renhui Biopharmaceutical Co., Ltd. Latest Developments
Table 133. Jiangsu Hansoh Pharmaceutical Group Co., Ltd. Basic Information, GLP-1 Drug Manufacturing Base, Sales Area and Its Competitors
Table 134. Jiangsu Hansoh Pharmaceutical Group Co., Ltd. GLP-1 Drug Product Portfolios and Specifications
Table 135. Jiangsu Hansoh Pharmaceutical Group Co., Ltd. GLP-1 Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 136. Jiangsu Hansoh Pharmaceutical Group Co., Ltd. Main Business
Table 137. Jiangsu Hansoh Pharmaceutical Group Co., Ltd. Latest Developments
LIST OF FIGURES
Figure 1. Picture of GLP-1 Drug
Figure 2. GLP-1 Drug Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global GLP-1 Drug Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global GLP-1 Drug Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. GLP-1 Drug Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Short-acting GLP-1 Drug
Figure 10. Product Picture of Long-acting GLP-1 Drug
Figure 11. Global GLP-1 Drug Sales Market Share by Type in 2022
Figure 12. Global GLP-1 Drug Revenue Market Share by Type (2018-2023)
Figure 13. GLP-1 Drug Consumed in Obesity
Figure 14. Global GLP-1 Drug Market: Obesity (2018-2023) & (K Units)
Figure 15. GLP-1 Drug Consumed in Type 2 Diabetes (T2DM)
Figure 16. Global GLP-1 Drug Market: Type 2 Diabetes (T2DM) (2018-2023) & (K Units)
Figure 17. GLP-1 Drug Consumed in Cardiovascular and Cerebrovascular Diseases (CVD)
Figure 18. Global GLP-1 Drug Market: Cardiovascular and Cerebrovascular Diseases (CVD) (2018-2023) & (K Units)
Figure 19. GLP-1 Drug Consumed in Non-alcoholic Steatohepatitis (NASH)
Figure 20. Global GLP-1 Drug Market: Non-alcoholic Steatohepatitis (NASH) (2018-2023) & (K Units)
Figure 21. GLP-1 Drug Consumed in Alzheimer's Disease (AD)
Figure 22. Global GLP-1 Drug Market: Alzheimer's Disease (AD) (2018-2023) & (K Units)
Figure 23. Global GLP-1 Drug Sales Market Share by Application (2022)
Figure 24. Global GLP-1 Drug Revenue Market Share by Application in 2022
Figure 25. GLP-1 Drug Sales Market by Company in 2022 (K Units)
Figure 26. Global GLP-1 Drug Sales Market Share by Company in 2022
Figure 27. GLP-1 Drug Revenue Market by Company in 2022 ($ Million)
Figure 28. Global GLP-1 Drug Revenue Market Share by Company in 2022
Figure 29. Global GLP-1 Drug Sales Market Share by Geographic Region (2018-2023)
Figure 30. Global GLP-1 Drug Revenue Market Share by Geographic Region in 2022
Figure 31. Americas GLP-1 Drug Sales 2018-2023 (K Units)
Figure 32. Americas GLP-1 Drug Revenue 2018-2023 ($ Millions)
Figure 33. APAC GLP-1 Drug Sales 2018-2023 (K Units)
Figure 34. APAC GLP-1 Drug Revenue 2018-2023 ($ Millions)
Figure 35. Europe GLP-1 Drug Sales 2018-2023 (K Units)
Figure 36. Europe GLP-1 Drug Revenue 2018-2023 ($ Millions)
Figure 37. Middle East & Africa GLP-1 Drug Sales 2018-2023 (K Units)
Figure 38. Middle East & Africa GLP-1 Drug Revenue 2018-2023 ($ Millions)
Figure 39. Americas GLP-1 Drug Sales Market Share by Country in 2022
Figure 40. Americas GLP-1 Drug Revenue Market Share by Country in 2022
Figure 41. Americas GLP-1 Drug Sales Market Share by Type (2018-2023)
Figure 42. Americas GLP-1 Drug Sales Market Share by Application (2018-2023)
Figure 43. United States GLP-1 Drug Revenue Growth 2018-2023 ($ Millions)
Figure 44. Canada GLP-1 Drug Revenue Growth 2018-2023 ($ Millions)
Figure 45. Mexico GLP-1 Drug Revenue Growth 2018-2023 ($ Millions)
Figure 46. Brazil GLP-1 Drug Revenue Growth 2018-2023 ($ Millions)
Figure 47. APAC GLP-1 Drug Sales Market Share by Region in 2022
Figure 48. APAC GLP-1 Drug Revenue Market Share by Regions in 2022
Figure 49. APAC GLP-1 Drug Sales Market Share by Type (2018-2023)
Figure 50. APAC GLP-1 Drug Sales Market Share by Application (2018-2023)
Figure 51. China GLP-1 Drug Revenue Growth 2018-2023 ($ Millions)
Figure 52. Japan GLP-1 Drug Revenue Growth 2018-2023 ($ Millions)
Figure 53. South Korea GLP-1 Drug Revenue Growth 2018-2023 ($ Millions)
Figure 54. Southeast Asia GLP-1 Drug Revenue Growth 2018-2023 ($ Millions)
Figure 55. India GLP-1 Drug Revenue Growth 2018-2023 ($ Millions)
Figure 56. Australia GLP-1 Drug Revenue Growth 2018-2023 ($ Millions)
Figure 57. China Taiwan GLP-1 Drug Revenue Growth 2018-2023 ($ Millions)
Figure 58. Europe GLP-1 Drug Sales Market Share by Country in 2022
Figure 59. Europe GLP-1 Drug Revenue Market Share by Country in 2022
Figure 60. Europe GLP-1 Drug Sales Market Share by Type (2018-2023)
Figure 61. Europe GLP-1 Drug Sales Market Share by Application (2018-2023)
Figure 62. Germany GLP-1 Drug Revenue Growth 2018-2023 ($ Millions)
Figure 63. France GLP-1 Drug Revenue Growth 2018-2023 ($ Millions)
Figure 64. UK GLP-1 Drug Revenue Growth 2018-2023 ($ Millions)
Figure 65. Italy GLP-1 Drug Revenue Growth 2018-2023 ($ Millions)
Figure 66. Russia GLP-1 Drug Revenue Growth 2018-2023 ($ Millions)
Figure 67. Middle East & Africa GLP-1 Drug Sales Market Share by Country in 2022
Figure 68. Middle East & Africa GLP-1 Drug Revenue Market Share by Country in 2022
Figure 69. Middle East & Africa GLP-1 Drug Sales Market Share by Type (2018-2023)
Figure 70. Middle East & Africa GLP-1 Drug Sales Market Share by Application (2018-2023)
Figure 71. Egypt GLP-1 Drug Revenue Growth 2018-2023 ($ Millions)
Figure 72. South Africa GLP-1 Drug Revenue Growth 2018-2023 ($ Millions)
Figure 73. Israel GLP-1 Drug Revenue Growth 2018-2023 ($ Millions)
Figure 74. Turkey GLP-1 Drug Revenue Growth 2018-2023 ($ Millions)
Figure 75. GCC Country GLP-1 Drug Revenue Growth 2018-2023 ($ Millions)
Figure 76. Manufacturing Cost Structure Analysis of GLP-1 Drug in 2022
Figure 77. Manufacturing Process Analysis of GLP-1 Drug
Figure 78. Industry Chain Structure of GLP-1 Drug
Figure 79. Channels of Distribution
Figure 80. Global GLP-1 Drug Sales Market Forecast by Region (2024-2029)
Figure 81. Global GLP-1 Drug Revenue Market Share Forecast by Region (2024-2029)
Figure 82. Global GLP-1 Drug Sales Market Share Forecast by Type (2024-2029)
Figure 83. Global GLP-1 Drug Revenue Market Share Forecast by Type (2024-2029)
Figure 84. Global GLP-1 Drug Sales Market Share Forecast by Application (2024-2029)
Figure 85. Global GLP-1 Drug Revenue Market Share Forecast by Application (2024-2029)
Figure 1. Picture of GLP-1 Drug
Figure 2. GLP-1 Drug Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global GLP-1 Drug Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global GLP-1 Drug Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. GLP-1 Drug Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Short-acting GLP-1 Drug
Figure 10. Product Picture of Long-acting GLP-1 Drug
Figure 11. Global GLP-1 Drug Sales Market Share by Type in 2022
Figure 12. Global GLP-1 Drug Revenue Market Share by Type (2018-2023)
Figure 13. GLP-1 Drug Consumed in Obesity
Figure 14. Global GLP-1 Drug Market: Obesity (2018-2023) & (K Units)
Figure 15. GLP-1 Drug Consumed in Type 2 Diabetes (T2DM)
Figure 16. Global GLP-1 Drug Market: Type 2 Diabetes (T2DM) (2018-2023) & (K Units)
Figure 17. GLP-1 Drug Consumed in Cardiovascular and Cerebrovascular Diseases (CVD)
Figure 18. Global GLP-1 Drug Market: Cardiovascular and Cerebrovascular Diseases (CVD) (2018-2023) & (K Units)
Figure 19. GLP-1 Drug Consumed in Non-alcoholic Steatohepatitis (NASH)
Figure 20. Global GLP-1 Drug Market: Non-alcoholic Steatohepatitis (NASH) (2018-2023) & (K Units)
Figure 21. GLP-1 Drug Consumed in Alzheimer's Disease (AD)
Figure 22. Global GLP-1 Drug Market: Alzheimer's Disease (AD) (2018-2023) & (K Units)
Figure 23. Global GLP-1 Drug Sales Market Share by Application (2022)
Figure 24. Global GLP-1 Drug Revenue Market Share by Application in 2022
Figure 25. GLP-1 Drug Sales Market by Company in 2022 (K Units)
Figure 26. Global GLP-1 Drug Sales Market Share by Company in 2022
Figure 27. GLP-1 Drug Revenue Market by Company in 2022 ($ Million)
Figure 28. Global GLP-1 Drug Revenue Market Share by Company in 2022
Figure 29. Global GLP-1 Drug Sales Market Share by Geographic Region (2018-2023)
Figure 30. Global GLP-1 Drug Revenue Market Share by Geographic Region in 2022
Figure 31. Americas GLP-1 Drug Sales 2018-2023 (K Units)
Figure 32. Americas GLP-1 Drug Revenue 2018-2023 ($ Millions)
Figure 33. APAC GLP-1 Drug Sales 2018-2023 (K Units)
Figure 34. APAC GLP-1 Drug Revenue 2018-2023 ($ Millions)
Figure 35. Europe GLP-1 Drug Sales 2018-2023 (K Units)
Figure 36. Europe GLP-1 Drug Revenue 2018-2023 ($ Millions)
Figure 37. Middle East & Africa GLP-1 Drug Sales 2018-2023 (K Units)
Figure 38. Middle East & Africa GLP-1 Drug Revenue 2018-2023 ($ Millions)
Figure 39. Americas GLP-1 Drug Sales Market Share by Country in 2022
Figure 40. Americas GLP-1 Drug Revenue Market Share by Country in 2022
Figure 41. Americas GLP-1 Drug Sales Market Share by Type (2018-2023)
Figure 42. Americas GLP-1 Drug Sales Market Share by Application (2018-2023)
Figure 43. United States GLP-1 Drug Revenue Growth 2018-2023 ($ Millions)
Figure 44. Canada GLP-1 Drug Revenue Growth 2018-2023 ($ Millions)
Figure 45. Mexico GLP-1 Drug Revenue Growth 2018-2023 ($ Millions)
Figure 46. Brazil GLP-1 Drug Revenue Growth 2018-2023 ($ Millions)
Figure 47. APAC GLP-1 Drug Sales Market Share by Region in 2022
Figure 48. APAC GLP-1 Drug Revenue Market Share by Regions in 2022
Figure 49. APAC GLP-1 Drug Sales Market Share by Type (2018-2023)
Figure 50. APAC GLP-1 Drug Sales Market Share by Application (2018-2023)
Figure 51. China GLP-1 Drug Revenue Growth 2018-2023 ($ Millions)
Figure 52. Japan GLP-1 Drug Revenue Growth 2018-2023 ($ Millions)
Figure 53. South Korea GLP-1 Drug Revenue Growth 2018-2023 ($ Millions)
Figure 54. Southeast Asia GLP-1 Drug Revenue Growth 2018-2023 ($ Millions)
Figure 55. India GLP-1 Drug Revenue Growth 2018-2023 ($ Millions)
Figure 56. Australia GLP-1 Drug Revenue Growth 2018-2023 ($ Millions)
Figure 57. China Taiwan GLP-1 Drug Revenue Growth 2018-2023 ($ Millions)
Figure 58. Europe GLP-1 Drug Sales Market Share by Country in 2022
Figure 59. Europe GLP-1 Drug Revenue Market Share by Country in 2022
Figure 60. Europe GLP-1 Drug Sales Market Share by Type (2018-2023)
Figure 61. Europe GLP-1 Drug Sales Market Share by Application (2018-2023)
Figure 62. Germany GLP-1 Drug Revenue Growth 2018-2023 ($ Millions)
Figure 63. France GLP-1 Drug Revenue Growth 2018-2023 ($ Millions)
Figure 64. UK GLP-1 Drug Revenue Growth 2018-2023 ($ Millions)
Figure 65. Italy GLP-1 Drug Revenue Growth 2018-2023 ($ Millions)
Figure 66. Russia GLP-1 Drug Revenue Growth 2018-2023 ($ Millions)
Figure 67. Middle East & Africa GLP-1 Drug Sales Market Share by Country in 2022
Figure 68. Middle East & Africa GLP-1 Drug Revenue Market Share by Country in 2022
Figure 69. Middle East & Africa GLP-1 Drug Sales Market Share by Type (2018-2023)
Figure 70. Middle East & Africa GLP-1 Drug Sales Market Share by Application (2018-2023)
Figure 71. Egypt GLP-1 Drug Revenue Growth 2018-2023 ($ Millions)
Figure 72. South Africa GLP-1 Drug Revenue Growth 2018-2023 ($ Millions)
Figure 73. Israel GLP-1 Drug Revenue Growth 2018-2023 ($ Millions)
Figure 74. Turkey GLP-1 Drug Revenue Growth 2018-2023 ($ Millions)
Figure 75. GCC Country GLP-1 Drug Revenue Growth 2018-2023 ($ Millions)
Figure 76. Manufacturing Cost Structure Analysis of GLP-1 Drug in 2022
Figure 77. Manufacturing Process Analysis of GLP-1 Drug
Figure 78. Industry Chain Structure of GLP-1 Drug
Figure 79. Channels of Distribution
Figure 80. Global GLP-1 Drug Sales Market Forecast by Region (2024-2029)
Figure 81. Global GLP-1 Drug Revenue Market Share Forecast by Region (2024-2029)
Figure 82. Global GLP-1 Drug Sales Market Share Forecast by Type (2024-2029)
Figure 83. Global GLP-1 Drug Revenue Market Share Forecast by Type (2024-2029)
Figure 84. Global GLP-1 Drug Sales Market Share Forecast by Application (2024-2029)
Figure 85. Global GLP-1 Drug Revenue Market Share Forecast by Application (2024-2029)
